Literature DB >> 28543924

Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients.

Yan Xia1, Dawei Wang2, Nan Zhang2, Zhihao Wang3, Li Pang2.   

Abstract

AIM: To investigate the prognostic value of plasma serotonin levels in colorectal cancer (CRC). PATIENTS AND METHODS: Preoperative plasma serotonin levels of 150 healthy control (HC) cases, 150 benign colorectal polyp (BCP) cases, and 176 CRC cases were determined using radioimmunoassay assay. Serotonin levels were compared between HC, BCP, and CRC cases, and those in CRC patients were related to 5-year outcome.
RESULTS: Plasma serotonin levels were markedly higher in CRC patients than in either HCs or BCP cases. An elevated serotonin level was significantly associated with advanced tumor node metastasis. Receiver operating characteristic curve analysis showed that the level of serotonin had a high predictive value for disease recurrence and mortality. Multivariate analysis revealed that high serotonin level was significantly associated with poor recurrence-free survival and overall survival.
CONCLUSION: Our results suggest that a high peri-operative plasma serotonin level is useful as a prognostic biomarker for CRC recurrence and poor survival.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarker; colorectal cancer; plasma serotonin

Mesh:

Substances:

Year:  2017        PMID: 28543924      PMCID: PMC6816875          DOI: 10.1002/jcla.22263

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  29 in total

1.  Determination of plasma serotonin and 5-hydroxyindoleacetic acid in healthy subjects and cancer patients.

Authors:  M S Lee; F C Cheng; H Z Yeh; T Y Liou; J H Liu
Journal:  Clin Chem       Date:  2000-03       Impact factor: 8.327

Review 2.  Serotoninergic neuroenteric modulators.

Authors:  N J Talley
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

Review 3.  Serotonin: a different player in hypertension-associated thrombosis.

Authors:  Mony Fraer; Fusun Kilic
Journal:  Hypertension       Date:  2015-03-09       Impact factor: 10.190

Review 4.  The role of serotonin in tumour growth (review).

Authors:  Emad J Siddiqui; Cecil S Thompson; Dimitri P Mikhailidis; Faiz H Mumtaz
Journal:  Oncol Rep       Date:  2005-12       Impact factor: 3.906

5.  Sensitization of the histamine H1 receptor by increased ligand affinity.

Authors:  S M Bloemers; S Verheule; M P Peppelenbosch; M J Smit; L G Tertoolen; S de Laat
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

6.  Decrease in platelet serotonin level in uterine cervix cancer patients.

Authors:  C Deb; C Lakshmi; C Ray; M R Ray
Journal:  Haematologia (Budap)       Date:  2001

7.  The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin.

Authors:  Brigitte Sonier; Madeleine Arseneault; Carole Lavigne; Rodney J Ouellette; Cathy Vaillancourt
Journal:  Biochem Biophys Res Commun       Date:  2006-03-24       Impact factor: 3.575

8.  Serotonin promotes tumor growth in human hepatocellular cancer.

Authors:  Christopher Soll; Jae Hwi Jang; Marc-Oliver Riener; Wolfgang Moritz; Peter Johannes Wild; Rolf Graf; Pierre-Alain Clavien
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

9.  The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation.

Authors:  Emad J Siddiqui; Majid A Shabbir; Dimitri P Mikhailidis; Faiz H Mumtaz; Cecil S Thompson
Journal:  BJU Int       Date:  2006-03       Impact factor: 5.588

Review 10.  Serotonin paracrine signaling in tissue fibrosis.

Authors:  Derek A Mann; Fiona Oakley
Journal:  Biochim Biophys Acta       Date:  2012-09-29
View more
  6 in total

1.  Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients.

Authors:  Yan Xia; Dawei Wang; Nan Zhang; Zhihao Wang; Li Pang
Journal:  J Clin Lab Anal       Date:  2017-05-22       Impact factor: 2.352

2.  Preoperative Serum and Intra-platelet Serotonin in Prognosis: Useful or Useless?

Authors:  Qinling Yang; Sushun Liu; Chaoling Deng; Bo Shu; Jingyao Zhang; Mimi Zhai
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

Review 3.  The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management.

Authors:  Aldona Kasprzak; Agnieszka Adamek
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

4.  Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment.

Authors:  Di Ye; Huanji Xu; Hongwei Xia; Chenliang Zhang; Qiulin Tang; Feng Bi
Journal:  J Exp Clin Cancer Res       Date:  2021-05-18

Review 5.  The Role of Serotonin in Breast Cancer Stem Cells.

Authors:  William D Gwynne; Mirza S Shakeel; Adele Girgis-Gabardo; John A Hassell
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.411

6.  Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies.

Authors:  Nikos Papadimitriou; Marc J Gunter; Neil Murphy; Audrey Gicquiau; David Achaintre; Stefanie Brezina; Tanja Gumpenberger; Andreas Baierl; Jennifer Ose; Anne J M R Geijsen; Eline H van Roekel; Andrea Gsur; Biljana Gigic; Nina Habermann; Cornelia M Ulrich; Ellen Kampman; Matty P Weijenberg; Per Magne Ueland; Rudolf Kaaks; Verena Katzke; Vittorio Krogh; Bas Bueno-de-Mesquita; Eva Ardanaz; Ruth C Travis; Matthias B Schulze; Maria-José Sánchez; Sandra M Colorado-Yohar; Elisabete Weiderpass; Augustin Scalbert; Pekka Keski-Rahkonen
Journal:  Int J Cancer       Date:  2021-07-12       Impact factor: 7.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.